Tags: Drug.

α5IA (LS-193268) is a nootropic drug invented in 2004 by a team working for Merck Sharp and Dohme which acts as a subtype-selective inverse agonist at the benzodiazepine binding site on the GABAA receptor.

Alpha5IA.png
ATC prefix
none
CAS number
215874-86-5
IUPAC name
3-​(5-​methylisoxazol-​3-​yl)-​6-​[(1-​methyl-​1H-​123-​triazol-​4-​yl)​methoxy]​[124]triazolo​[34-​a]phthalazine
PubChem
6918451

Loading...

This page contains content from the copyrighted Wikipedia article "Α5IA"; that content is used under the GNU Free Documentation License (GFDL). You may redistribute it, verbatim or modified, providing that you comply with the terms of the GFDL.